Endpoints News unveiled its 2025 Endpoints 11 winners spotlighting leading-edge biotech startups transforming drug discovery and therapies. Companies like Chai Discovery are harnessing AI for computational drug design, Umoja Biopharma aims to overcome in vivo CAR-T therapy barriers, and Candid Therapeutics builds next-generation autoimmune disease treatments. Others, such as Orbis Medicines, Dispatch Bio, and Sironax, target macrocycles, solid tumor cell therapies, and neurology advancements. This cohort reflects diverse technological breakthroughs with potential to impact oncology, immunology, and gene therapy pipelines.